Cell/Gene Tx channel feed – Endpoints News

Cell/Gene Tx channel feed

Epidarex, Sofinnova double down on a parallel take on 3rd-gen CAR-T — aiming straight at ovarian cancer

4 years ago

Carl June lends 'wings' to Chinese CAR-T startup led by former postdoc, pursuing off-the-shelf approach with CRISPR flavor

4 years ago

Vertex gets much-needed win with ‘extraordinary’ first patient results on potential diabetes cure

4 years ago

Drawn to the idea of turning B cells into 'protein factories,' Takeda jumps into a milestone-heavy, $900M pact

4 years ago

Intellia enters Editas’ turf with ocular CRISPR pact

4 years ago

CRISPR Therapeutics claims safety advantage in first big look at off-the-shelf CAR-T data, but durability in question

4 years ago

Takeda enlists Poseida in $3.6B+ nonviral gene therapy deal, though data remain years away from human studies

4 years ago

After three decades and a surprise rejection, first treatment for babies born without a thymus secures FDA approval

4 years ago

Searching for the next 'big hairy goal,' BlueRock CEO Emile Nuwaysir jumps to in vivo cell therapy startup Ensoma

4 years ago

Tiny player picks up $30M to go after CAR-T's biggest challenges

4 years ago

Troubled Voyager’s gene therapy relaunch gets a boost with $630M Pfizer deal

4 years ago

Estate of Henrietta Lacks sues Thermo Fisher over the improper sale of her immortal cells

4 years ago

Has Selecta found a way around gene therapy's delivery problem? Takeda puts down $1B-plus to find out

4 years ago

Editas' CRISPR-based eye therapy proves safe, but the jury's still out on whether it works

4 years ago

Safety fears force Pfizer to change pivotal DMD gene therapy trial protocol

4 years ago

Microcap gene therapy player says three children suffered serious side effects in PhI/II study

4 years ago

UNC researchers report a new way to charge CAR-T against solid tumors

4 years ago

Diving deeper into inherited retinal disorders, Novartis gobbles up another bite-sized optogenetics biotech

4 years ago

Zolgensma patent spat brews between Novartis and Regenxbio as top Novartis gene therapy exec departs

4 years ago

The biggest questions facing gene therapy, the XLMTM community, and Astellas after fourth patient death

4 years ago

Looking for the next mRNA breakthrough, Moderna taps AbCellera in mysterious antibody discovery deal

4 years ago

Fourth boy dies in Astellas-Audentes gene therapy trial, raising fresh fears for the field

4 years ago

French biotech raises $75M for new cell therapy manufacturing tech, Parkinson's treatment

4 years ago

Jennifer Doudna's diagnostic spinout raises Mammoth round as it expands to therapies

4 years ago

First page Previous page 35 36 373839 40 41 Next page Last page